CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at The Third Annual JMP Securities Healthcare Focus Conference on Tuesday, October 7, 2008, at 1:30 p.m. ET at Le Parker Meridien in New York City.
